KJ

Kamleshkumar Jaysukhbhai Sojitra

Active Director Director DIN 09352262
DIN 09352262 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamleshkumar Jaysukhbhai Sojitra

Data last updated:

Kamleshkumar Jaysukhbhai Sojitra is a Director at K J Pharmalab Private Limited (since 2021). The company operates in Trading.

DIN 09352262
Primary Designation Director
Industry Trading
First Appointment 08 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
K J Pharmalab Private Limited U51909GJ2021PTC126221
Director08 Oct 20212021Active

Board colleagues of Kamleshkumar Jaysukhbhai Sojitra

NameDINCompanyDesignation
Jay Dhanjibhai Gujarati06869099K J Pharmalab Private LimitedDirector

Directorship timeline

Open interactive timeline →
K J Pharmalab Private Limited
Premium access

Shareholding and investment profile for Kamleshkumar Jaysukhbhai Sojitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamleshkumar Jaysukhbhai Sojitra

Kamleshkumar Jaysukhbhai Sojitra currently holds 1 directorship: K J Pharmalab Private Limited (Director, since 08 Oct 2021).

Kamleshkumar Jaysukhbhai Sojitra was first appointed on 08 Oct 2021 as Director at K J Pharmalab Private Limited.

The current boards of Kamleshkumar Jaysukhbhai Sojitra's companies include Jay Dhanjibhai Gujarati (K J Pharmalab Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available